Intelligence Layer

Institutional Blind Spot Detection

Real-time threat detection across 13 global intelligence sources. The Cortex AI Engine identifies what you are uniquely positioned to miss — regulatory actions, clinical signals, market movements, and policy divergence that matter to your institution.

Request Intelligence Demo See Live Signals

Cortex AI Engine

What It Does

The Cortex AI Engine ingests heterogeneous signals from regulatory bodies, clinical data sources, financial markets, and global policy networks. It applies institutional context—your regulatory obligations, market footprint, pipeline status, and stakeholder exposure—to produce confidence-scored intelligence ranked by relevance and impact.

How It Works

Cortex maps raw signals onto a Johari Window framework: what you and the market both know (open), what you alone know (hidden), what you've missed that competitors see (blind), and what no one yet knows (unknown unknown). It surfaces signals that move between quadrants—especially blind spots that pose regulatory, competitive, or operational risk.

13 Global Intelligence Sources

FDA

U.S. regulatory actions: warnings, recalls, label changes, safety communications, enforcement notices, and advisory committee signals.

WHO

World Health Organization disease surveillance, outbreak notifications, emergency declarations, and policy guidance affecting global market access.

EMA

European Medicines Agency assessments, PRAC decisions, conditional approvals, post-authorization surveillance, and regulatory divergence signals.

NIH & PMDA

U.S. National Institutes of Health funding signals and Japanese Pharmaceuticals and Medical Devices Agency regulatory actions.

PubMed & bioRxiv

Scientific publication velocity, negative findings, mechanism-of-action challenges, and preprint early warnings from peer-reviewed and preprint sources.

Clinical Trials

ClinicalTrials.gov enrollment velocity, terminations, safety holds, recruitment changes, and competitive trial intelligence.

SEC & Financial

10-K filings, earnings call language, analyst downgrades, institutional repositioning, and credit market signals affecting competitive standing.

Patent & IP

Patent office actions, opposition filings, freedom-to-operate risks, and competitive patent strategy signals.

Policy & Legislative

Congressional actions, health ministry policy proposals, reimbursement policy shifts, and regulatory divergence signals.

Confidence Scoring

Every signal carries a confidence score (0-100) representing the AI's probability that the signal indicates genuine, actionable risk. Confidence incorporates source reliability, temporal proximity, corroboration from multiple sources, and institutional context. No signal above 85 confidence appears without human validation. No score is absolute—only calibrated.

92%
High Confidence

Multiple source corroboration, recent, institutional match.

67%
Medium Confidence

Single source, emerging pattern, temporal uncertainty.

41%
Low Confidence

Early signal, weak source, institutional mismatch.

The Johari Window: Signal Mapping

Every signal belongs to one of four quadrants. Cortex identifies signals moving into or within the "Blind Spot" quadrant—threats you are uniquely positioned to miss because they violate consensus assumptions about your market.

Open Knowledge
You and the market both know it. Regulatory changes, competitor announcements, published trial results. Critical for timeline awareness.
Blind Spot
Competitors and the market see it; you do not. Emerging resistance patterns, negative preprints, policy drift, financial instability signals. This is Cortex's primary target.
Unknown Unknown
No one yet knows. Emerging pathogens, novel biomarkers, unanticipated regulatory action. Cortex flags early weak signals before certainty exists.

How Intelligence Discovery Works

1

Ingest

13 signal sources update hourly. Each source is normalized to common signal schema: source ID, signal title, evidence text, metadata (dates, actors, quantification), and source reliability score.

2

Classify

Signal is assigned to signal type (regulatory action, clinical trial event, publication, policy, financial, etc.) and mapped to your institutional context: which products, markets, and obligations apply.

3

Score

Cortex AI produces confidence score (0-100) and Johari quadrant classification. Score reflects source reliability, corroboration, temporal proximity, and institutional risk exposure.

4

Validate

Signals at or above 85 confidence are routed to your operations and legal teams for institutional validation. Feedback refines the scoring model over time.

5

Alert

Blind spot signals enter your escalation workflow. You own the decision: act, monitor, or ignore. Cortex tracks outcome and adjusts confidence calibration.

Why This Matters

Regulatory Risk

FDA enforcement actions, label changes, and adverse event patterns often appear in publications, trial registries, or policy discussions before formal agency communication. Cortex detects these signals weeks or months before official regulatory action, giving your compliance team time to respond.

Competitive Intelligence

Patent office actions, clinical trial enrollment velocity, and analyst commentary reveal competitor pipeline strength, manufacturing challenges, and market repositioning before earnings calls. Cortex surfaces these blind spots automatically.

Market Access & Pricing

Reimbursement policy, health ministry decisions, and payer signals ripple through publications, policy databases, and financial markets. Cortex maps these waves in real time across your therapeutic areas and geographies.

Institutional Accountability

Regulators, investors, and boards expect that institutional actors monitor signals relevant to their sector. Cortex provides evidence that you are doing so—defense against claims of negligent blindness.

Request Intelligence Demo

See how Cortex identifies blind spots specific to your institution. 30-minute walkthrough with your regulatory and intelligence leads.

Request Demo